B3GNT6
Basic information
Region (hg38): 11:77034398-77041973
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the B3GNT6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 28 | 0 | 0 |
Variants in B3GNT6
This is a list of pathogenic ClinVar variants found in the B3GNT6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-77039567-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
11-77039684-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
11-77039686-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
11-77039726-G-A | not specified | Uncertain significance (Oct 21, 2021) | ||
11-77039756-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
11-77039814-G-T | not specified | Uncertain significance (Feb 05, 2024) | ||
11-77039819-C-A | not specified | Uncertain significance (Dec 14, 2023) | ||
11-77039886-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
11-77039891-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
11-77039963-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
11-77039985-G-C | not specified | Uncertain significance (Sep 06, 2022) | ||
11-77040002-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
11-77040005-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
11-77040006-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
11-77040008-C-T | not specified | Uncertain significance (Oct 18, 2021) | ||
11-77040012-T-C | not specified | Uncertain significance (May 31, 2023) | ||
11-77040023-G-T | not specified | Uncertain significance (Jun 06, 2023) | ||
11-77040024-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
11-77040036-C-T | not specified | Uncertain significance (Dec 20, 2021) | ||
11-77040039-A-T | not specified | Uncertain significance (Jun 10, 2024) | ||
11-77040041-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
11-77040103-C-G | Childhood-onset schizophrenia | Likely pathogenic (Jan 01, 2014) | ||
11-77040104-G-A | not specified | Uncertain significance (May 01, 2024) | ||
11-77040194-G-C | not specified | Uncertain significance (Nov 22, 2021) | ||
11-77040221-G-A | not specified | Uncertain significance (Nov 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
B3GNT6 | protein_coding | protein_coding | ENST00000533140 | 1 | 7712 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.09e-9 | 0.0267 | 124594 | 0 | 48 | 124642 | 0.000193 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.216 | 247 | 238 | 1.04 | 0.0000152 | 2359 |
Missense in Polyphen | 96 | 85.173 | 1.1271 | 918 | ||
Synonymous | 0.400 | 108 | 113 | 0.952 | 0.00000782 | 826 |
Loss of Function | -0.935 | 12 | 8.98 | 1.34 | 4.47e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000766 | 0.000684 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000229 | 0.000223 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000207 | 0.000186 |
Middle Eastern | 0.000229 | 0.000223 |
South Asian | 0.000211 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Beta-1,3-N-acetylglucosaminyltransferase that synthesizes the core 3 structure of the O-glycan, an important precursor in the biosynthesis of mucin-type glycoproteins. Plays an important role in the synthesis of mucin-type O-glycans in digestive organs.;
- Pathway
- Mucin type O-glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;O-Glycan biosynthesis;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.285
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- B3gnt6
- Phenotype
- digestive/alimentary phenotype; immune system phenotype; neoplasm; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- protein glycosylation;glycoprotein biosynthetic process;O-glycan processing;O-glycan processing, core 3;poly-N-acetyllactosamine biosynthetic process
- Cellular component
- Golgi membrane;endoplasmic reticulum;Golgi apparatus;membrane;integral component of membrane
- Molecular function
- acetylgalactosaminyltransferase activity;galactosyltransferase activity;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity;N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity;acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity